Clarius Group LLC Has $834,000 Stake in Danaher Co. (NYSE:DHR)

Clarius Group LLC reduced its position in shares of Danaher Co. (NYSE:DHR) by 9.0% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 5,188 shares of the conglomerate’s stock after selling 514 shares during the quarter. Clarius Group LLC’s holdings in Danaher were worth $834,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of DHR. Parnassus Investments CA boosted its stake in shares of Danaher by 1.2% in the 3rd quarter. Parnassus Investments CA now owns 4,772,773 shares of the conglomerate’s stock valued at $689,332,000 after purchasing an additional 54,323 shares in the last quarter. Nuveen Asset Management LLC raised its holdings in Danaher by 10,853.5% during the 2nd quarter. Nuveen Asset Management LLC now owns 3,664,924 shares of the conglomerate’s stock worth $523,790,000 after purchasing an additional 3,631,465 shares during the last quarter. Pictet Asset Management Ltd. raised its holdings in Danaher by 2.5% during the 3rd quarter. Pictet Asset Management Ltd. now owns 2,984,305 shares of the conglomerate’s stock worth $431,023,000 after purchasing an additional 73,456 shares during the last quarter. Sumitomo Mitsui Trust Holdings Inc. raised its holdings in Danaher by 4.6% during the 3rd quarter. Sumitomo Mitsui Trust Holdings Inc. now owns 2,947,171 shares of the conglomerate’s stock worth $425,660,000 after purchasing an additional 129,650 shares during the last quarter. Finally, CIBC Private Wealth Group LLC raised its holdings in Danaher by 7.5% during the 3rd quarter. CIBC Private Wealth Group LLC now owns 2,797,640 shares of the conglomerate’s stock worth $404,063,000 after purchasing an additional 194,457 shares during the last quarter. 78.04% of the stock is currently owned by hedge funds and other institutional investors.

Shares of NYSE:DHR traded up $0.02 during mid-day trading on Wednesday, hitting $163.73. The company had a trading volume of 66,302 shares, compared to its average volume of 1,970,862. The firm has a fifty day moving average price of $153.92 and a 200 day moving average price of $143.85. The company has a market capitalization of $117.12 billion, a PE ratio of 48.63, a price-to-earnings-growth ratio of 2.59 and a beta of 0.93. The company has a debt-to-equity ratio of 0.52, a current ratio of 3.43 and a quick ratio of 3.09. Danaher Co. has a one year low of $104.50 and a one year high of $164.17.

Danaher (NYSE:DHR) last released its quarterly earnings data on Thursday, October 24th. The conglomerate reported $1.16 earnings per share for the quarter, beating the consensus estimate of $1.15 by $0.01. Danaher had a net margin of 12.13% and a return on equity of 11.42%. The company had revenue of $5.04 billion during the quarter, compared to analyst estimates of $5.02 billion. During the same quarter in the previous year, the business posted $1.10 EPS. Danaher’s revenue for the quarter was up 3.8% compared to the same quarter last year. Research analysts expect that Danaher Co. will post 4.66 earnings per share for the current fiscal year.

The firm also recently declared a quarterly dividend, which will be paid on Friday, January 31st. Investors of record on Friday, December 27th will be given a $0.17 dividend. This represents a $0.68 annualized dividend and a yield of 0.42%. The ex-dividend date of this dividend is Thursday, December 26th. Danaher’s payout ratio is currently 15.04%.

Several research firms have issued reports on DHR. Citigroup began coverage on shares of Danaher in a report on Monday, January 6th. They set a “buy” rating and a $180.00 price target for the company. Wells Fargo & Co began coverage on shares of Danaher in a report on Tuesday, January 7th. They set an “overweight” rating and a $170.00 price target for the company. Needham & Company LLC raised their price target on shares of Danaher from $152.00 to $167.00 and gave the stock a “buy” rating in a report on Thursday, January 2nd. Credit Suisse Group raised their price target on shares of Danaher from $151.00 to $160.00 and gave the stock an “outperform” rating in a report on Thursday, December 19th. Finally, ValuEngine lowered shares of Danaher from a “buy” rating to a “hold” rating in a research note on Wednesday, October 2nd. One research analyst has rated the stock with a sell rating, five have issued a hold rating and eleven have assigned a buy rating to the stock. The stock presently has a consensus rating of “Buy” and an average price target of $159.69.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company's Life Sciences segment provides mass spectrometers; cellular analysis, lab automation, and centrifugation instruments; microscopes; and genomics consumables.

Read More: Risk Tolerance

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Co. (NYSE:DHR).

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.